ArticleJCI insight2025

Treatment with efavirenz extends survival in a Creutzfeldt-Jakob disease model by regulating brain cholesterol metabolism.

Tahir Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.